Cancer and Translational Research Lab, Department of Biotechnology, Dr. D.Y. Patil Biotechnology & Bioinformatics Institute, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra 411033, India.
Curr Mol Med. 2021;21(3):177-181. doi: 10.2174/1566524020666200521075252.
Tumor heterogeneity is influenced by various factors including genetic, epigenetic and axis of metabolic-epigenomic regulation. In recent years, metabolic-epigenomic reprogramming has been considered as one of the many tumor hallmarks and it appears to be driven by both microenvironment and macroenvironment factors including diet, microbiota and environmental pressures. Epigenetically, histone lysine residues are altered by various post-translational modifications (PTMs) such as acetylation, acylation, methylation and lactylation. Furthermore, lactylation is suggested as a new form of PTM that uses a lactate substrate as a metabolic ink for epigenetic writer enzyme that remodels histone proteins. Therefore, preclinical and clinical attempts are warranted to disrupt the pathway of metabolic-epigenomic reprogramming that will turn pro-tumor microenvironment into an anti-tumor microenvironment. This paper highlights the metabolicepigenomic regulation events including lactylation and its metabolic substrate lactate in the tumor microenvironment.
肿瘤异质性受多种因素影响,包括遗传、表观遗传和代谢-表观遗传调控轴。近年来,代谢-表观遗传重编程被认为是肿瘤的许多标志之一,它似乎受到微环境和宏环境因素的驱动,包括饮食、微生物群和环境压力。在表观遗传上,组蛋白赖氨酸残基通过各种翻译后修饰(PTMs)改变,如乙酰化、酰化、甲基化和乳酰化。此外,乳酰化被认为是一种新的 PTM 形式,它使用乳酸盐作为代谢墨水,用于重塑组蛋白的表观遗传写入酶。因此,有必要进行临床前和临床尝试来破坏代谢-表观遗传重编程的途径,将促进肿瘤的微环境转化为抗肿瘤的微环境。本文重点介绍了代谢-表观遗传调控事件,包括肿瘤微环境中的乳酰化及其代谢底物乳酸盐。